Line 20: |
Line 20: |
| *FECoV may cause mild respiratory symptoms and diarrhoea but is often asymptomatic | | *FECoV may cause mild respiratory symptoms and diarrhoea but is often asymptomatic |
| *Weeks, months or years may intervene between localized primary FECoV infection and FIP development | | *Weeks, months or years may intervene between localized primary FECoV infection and FIP development |
| + | *FECoV replicates in the gut, but FIP spreads systemically in the circulation |
| *FIP gains ability to replicate in monocytes and macrophages | | *FIP gains ability to replicate in monocytes and macrophages |
− | *FECoV replicates in the gut, but FIP spreads systemically in the circulation
| |
| *Almost invariably '''fatal''' | | *Almost invariably '''fatal''' |
| *Failure of the immune system to clear antibody-antigen complexes leads to '''immune-mediated disease''' | | *Failure of the immune system to clear antibody-antigen complexes leads to '''immune-mediated disease''' |
| **Deposited complexes cause '''inflammation''' and '''exudation''' | | **Deposited complexes cause '''inflammation''' and '''exudation''' |
| **This leads to characteristic '''oedema''' as fibrin-rich serum escapes to intercellular spaces | | **This leads to characteristic '''oedema''' as fibrin-rich serum escapes to intercellular spaces |
− | *For more, see [[Intestines Granulomatous Enteritis - Pathology#Feline Infectious Peritonitis|here]] | + | ** [[Intestines Granulomatous Enteritis - Pathology#Feline Infectious Peritonitis|'''Pyogranulomas''']] can develop in major organs as a result of the immune response and the body's failure to clear away excess neutrophils |
| + | *Cats previously exposed to coronavirus (and therefore with circulating antibody) may be at greater risk as they are more susceptible to taking up virus into mononuclear cells |
| + | *Cats making a biased Th-1 response are more likely to evade infection, whereas cats making a balanced response are at moderate risk and cats making a biased Th-2 response are at greater risk, as the virus is best tackled by cell mediation and not antibody |
| + | *Cats compromised by '''immunosuppression''' (either iatrogenic or disease-related) are at a greater risk of developing FIP |
| + | Clinical signs: |
| + | *Chronic weight loss |
| + | *Anorexia |
| + | *Pyrexia |
| + | *Depression |
| + | *Fluid in the abdomen, thorax or pericardium symptomatic of '''wet, or exudative FIP''' |
| + | *Granulomatous change in the organs symptomatic of '''dry, or nonexudative FIP''' |
| + | Can be shown to cause: |
| + | *Uveitis |
| + | *Hydrocephalus |
| + | *Neurological symptoms, such as ataxia or seizures |
| + | *Chronic diarrhoea |
| | | |
| ====Epidemiology==== | | ====Epidemiology==== |
− | | + | *FECoV is '''endemic worldwide''', with the majority of cats showing a subclinical seroconversion |
| + | *'''Orofecal, aerosol, and contact''' transmission |
| + | *Particular concern for '''catteries''' and homes with '''multiple cats''' |
| + | *FIP arises from a '''mutation of FECoV''' (in 5-10% of chronically infected cats) and not directly from cat to cat |
| | | |
| ====Diagnosis==== | | ====Diagnosis==== |
− | *Serology is impossible as most cats will have antibody to FECoV | + | *Clinical signs |
| + | **FIP should be suspect in all cases of chronic weight loss or recurrent fever unresponsive to antibiotics, particularly in multiple cat situations |
| + | *Simple serology is impossible as most cats will have antibody to FECoV |
| + | *However, 4 indicators can be used to cross reference: |
| + | **High FECoV Ab titres |
| + | **Low albumin:globulin ratio in plasma/ascites (globulin levels rise in FIP) |
| + | **High levels of glycoprotein alpha 1-acid glycoprotein (AGP) |
| + | **Low white cell counts |
| + | *FIP antigen detection by '''immunofluorescence''' in macrophages gives a definite positive diagnosis |
| + | *PM: look for characteristic lesions in vascular immune complex disease and lymphoid infiltration |
| | | |
| ====Control==== | | ====Control==== |
| + | *Conventional vaccination is counterproductive as antibody worsens infection |
| + | *A non-systemic vaccine (Primucell) is available outside the UK |
| + | **Temperature-sensitive mutant |
| + | **Replication confined to nasal mucosa, providing local immunity and cell-mediated immunity |
| + | **Cannot protect cats already infected with FECoV |
| + | **Kittens must be isolated until old enough to vaccinate at 16 weeks |
| + | *Antibody tests are available to certify "FECoV-free" cat houses |